Want to join the conversation?
Pharma major $AGN said it filed a de novo application with the Food and Drug Administration (FDA) for the Oculeve Intranasal Tear Neurostimulator device, which increases tear production upon activation in patients with dry eye disease. De novo application is an alternate pathway to classify novel devices of low to moderate risk.
$SBUX launched its annual “Starbucks for Life” competition in the U.S. and Canada. The winner of the competition will receive a credit of one drink or food item per day for a duration of 30 years.
$T shares rose 1.8%, as a big boost for the S&P 500. The company said its new streaming television service DirectTV has so far exceeded expectations.
$TXMD flying high.. anyone here to catch..?
$CMG crashing. There seems to be nothing good to read about this company.